Evidence map›Paper›PMID 16021483›Full record

Trial reportPsychopharmacology2005

Cholinergic enhancement of episodic memory in healthy young adults.

Georg Grön, Matthias Kirstein, Axel Thielscher, Matthias W Riepe, Manfred Spitzer

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Trial
  5. Trial
  6. Trial
  7. Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease.Journal of the International Neuropsychological Society : JINS · 2009
    Trial
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neurocognitive challenges in brain tumor survivors: is there anything we can do?Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georg GrönDepartment of Psychiatry, University of Ulm, Leimgrubenweg 12, 89075 Ulm, Germany. georg.groen@medizin.uni-ulm.de
Matthias Kirstein
Axel Thielscher
Matthias W Riepe
Manfred Spitzer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAcetylcholine esterase (AchE) inhibitors are known to remediate symptoms of Alzheimer's disease. However, only few systematic data exist on the effects of cholinergic treatment on cognitive functions in normal subjects.

objectiveThis study evaluated the effects of donepezil, an inhibitor of AchE, on cognitive performance in young and healthy subjects.

methodsWe used a randomised double-blind parallel group placebo-controlled repeated measures design to investigate changes of cognitive functions in a group of 30 young healthy male subjects (mean age 23.9 years+/-2.24 SD) upon application of donepezil or placebo for 30 days. Attentional and executive functions, visual and verbal short-term and working memory, semantic memory, as well as verbal and visual episodic memory were investigated using an extensive neuropsychological test battery.

resultsTime-by-group interactions demonstrated significant drug effects that were specific to episodic memory in both the verbal and visual domain. Additionally, donezepil significantly improved long-term visual episodic recall. In none of the other functions under investigation any significant treatment effects were observed.

conclusionGiven this specific drug effect and the well-known relevance of the hippocampal region for episodic memory, we conclude that this region appears to be the major target of cholinergic enhancement in healthy subjects due to long-term inhibition of AchE.

Indexed as

Neuropsychological TestsAdultAttentionCholinesterase InhibitorsDiscrimination LearningDonepezilDouble-Blind MethodFemaleHippocampusHumansIndansMaleMemory, Short-TermMental RecallOrientationPattern Recognition, VisualCholinesterase InhibitorsDonepezilIndansPiperidines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.